Drugs / cellgram-spine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01676441 | Aug 2008 → Mar 2021 | spinal cord injury | Pharmicell Co., Ltd. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cellgram-spine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01676441 ↗ |
| Modality | Cell therapy | “autologous Mesenchymal Stem Cells (MSC) transplanted” NCT01676441 ↗ |
| Route | Intrathecal | “injected into the intramedullary and intrathecal space respectively” NCT01676441 ↗ |